Mitral regurgitation: Finding the right time for the right patient at iHF Course 2026

A must-attend session introduced by Emmanuele Barbato

Determining the right timing for intervention in secondary mitral regurgitation (MR) is one of the most complex decisions in heart failure with reduced ejection fraction (HFrEF) management. The balance between guideline-directed medical therapy optimization, hemodynamic assessment and percutaneous mitral intervention often defines patient outcomes.

In this video, Emmanuele Barbato explains why understanding MR timing is essential in daily practice, and why this session stands out in the iHF Course 2026 programme.

Mitral regurgitation: Finding the right time for the right patient

Friday 20 March • 16:15–17:15

What you will learn

During this case-based session, you’ll explore how to:

Define guideline-directed medical therapy in patients with HFrEF + secondary MR
Recognize key hemodynamic signatures, and understand how therapy can modify them
Use percutaneous intervention as a true GDMT enabler

All concepts are explored through a single evolving patient case, giving you a clear, real-world framework for MR decision-making and intervention timing.

Why you should attend

If you care for patients with HFrEF and secondary MR, this session will help you:

Improve your MR timing strategy
Recognize when GDMT alone is sufficient, and when the patient reaches a point where intervention timing becomes critical
Integrate hemodynamics, therapy response and percutaneous options into a coherent, patient-tailored strategy

You will leave with a more confident and structured approach to evaluating MR progression and selecting the right intervention at the right moment.